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1. Introduction 
The most commonly ordered test used for managing patients worldwide is the hemogram, 
with or without the review of a peripheral smear. The measured features in a standard 
hemogram has undergone modification of the over the last 30 years with an expansion to 
the panel of tests. The initial hemogram was the hemoglobin, hematocrit, and total white cell 
count, to which platelet count, lymphocytes and neutrophils were added as the necessary 
vital dye stains and the resolution were substantially improved. The revolutionary Coulter 
principle used impedance of the cells passing through a narrow window. Newer 
instruments may used both impedance and/or flow cytometric principles. Yet the accurate 
identification of reticulocytes, measurement of cellular hemoglobin, measurement of 
immature granulocytes, lymphoid or myeloblasts, identification of clumped platelets 
interfering with identification of large platelets were all challenges to overcome. The 
hemogram provides a vital window to visualize the cellular changes associated with the 
production, release or suppression of the formed elements from the blood forming organ to 
the circulation. In this chapter, we shall not be concerned with the specific use of the 
hemogram in assessing disorders to the coagulation pathways or its use in detection of 
hematological and non-hematological tumors. Rather in the hemogram we can view data 
reflective of a broad spectrum medical conditions affecting most patients presenting to a 
physician who are then referred to a specialist for example in hematology-oncology or 
infectious diseases. 
The theme of what we are about to present is that once we go beyond qualitative changes to 
the morphology of the cellular components of blood, we have also to consider their 
quantitative characteristics expressed as measurements of size, density, and concentration, 
which results in more than a dozen composite variables, including the mean corpuscular 
volume (MCV), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular 
hemoglobin (MCH), total white cell count (WBC), total lymphocyte count, neutrophil count 
(mature granulocyte count and bands), monocytes, eosinophils, basophils, platelet count, 
and mean platelet volume (MPV), and flags to denote blasts, reticulocytes, platelet clumps, 
and so on. If you were to add the comprehensive metabolic panel, which includes 
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monovalent and divalent cations and anions, total CO2, total protein and albumin, to name 
a few, there is a potential for information overload to the physician. These data in turn have 
to be comprehended in context with vital signs, key symptoms, and an accurate medical 
history. Consequently, the limits of memory and cognition are tested in medical practice on 
a daily basis. In this chapter we will discuss problems in the interpretation of data generated 
by automated laboratory diagnostic machinery, as experienced by the physician, and how 
through better design of the software (middleware) that presents this data the situation 
could be improved.  
2. The current status of the physician-laboratory interface 
The clinical laboratory has several divisions. Microbiology and anatomic pathology are the 
oldest, and they are the least automated, but they have rigorous definitions for their 
interpretation, as is true for immunohematology. Hematology and chemistry are the most 
automated, but their interpretations are more difficult than the other disciplines. To start 
with we will consider automated chemistry, hematology, and immunology with large high-
throughput sample platforms. These analyzers have enhanced performance by interface 
with middleware, which have embedded rules to accept or reject a test result based on a 
result lying outside an assigned confidence limit, or based on a difference from a previous 
measurement within an assigned time interval in hours or days. A middleware is a 
minicomputer installed either between an instrument and a laboratory information system 
or between an instrument and a hospital information system. The middleware handles an 
enormous transaction rate of test workflow that would otherwise compete with physician 
interactions in trying to access the data output. The middleware also carries out on-line 
quality control checks, monitors the completion of panel accessions, and does “delta” checks 
for excessive differences between measurements taken in sequence. Further, depending on 
whether a test is measured from unclotted and unspun blood, or from plasma or serum 
fraction, hematology, chemistry and immunology testing are tested with different 
turnaround times (time from receipt to time to report). In all of these cases, tests from 
different core “instruments” or laboratory “facilities” of laboratory testing have to be 
interpreted without conflict in the production “silo” (the term refers to a separate mode of 
production that is separate from and not interoperable with other information sources).  
3. Data overload and unstructured 
The computer architecture that the physician uses to view the results is not open-
architecture, and the middleware solutions used to overcome the problem are insufficient in 
that the data is not recombined from the rigid lists into a structured format that readily 
enables the physician to interpret the report. Consequently the results are more often than 
not presented as the designer would prefer, and not as the end-user would like. In order to 
optimize the interface for physician, the system would have a “front-to-back” design, with 
the call up for any patient ideally consisting of a dashboard design that presents the crucial 
information that the physician would likely act on in an easily accessible manner. The 
problem of the user having to adjust to what the system confronts them with is described by 
Didner (1) in an internal Bell Labs memo approved for external release. The key point being 
that each item used has to be closely related to a corresponding criterion needed for a 
decision. Currently, improved design is heading in that direction. In removing this 
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limitation the output requirements have to be defined before the database is designed to 
produce the required output. The ability to see any other information, or to see a sequential 
visualization of the patient’s course would be steps to home in on other views. In addition, 
the amount of relevant information, even when presented well, is a cognitive challenge 
unless it is presented in a disease- or organ-system structure. So the interaction between the 
user and the electronic medical record has a significant effect on practitioner time, ability to 
minimize errors of interpretation, facilitate treatment, and manage costs. This is a correction 
for a view from the mere transmission of a body of automated tests that are generated at 
sites not near to the patient, often with a high priority reporting required from the operating 
room, the emergency room, or the intensive care units in order to make triage decisions or to 
adjust fluids or make treatment decisions. 
The reality is that clinicians are challenged by the need to view a large amount of data, with 
only a few resources available to know which of these values are relevant, or the need for 
action on a result, or its urgency. An approach (2,3), called the foresighted-practice 
guideline, aligned with concepts developed by Lawrence Weed (4). Weed emphasizes that 
the information infrastructure was lacking at the time of his writing (1997), and that tools 
are needed to extend the mind’s capability to process large numbers of relevant variables. 
The challenge then becomes how fundamental measurement theory can lead to the creation 
at the point of care of more meaningful actionable presentations of results (5). WP Fisher (6) 
refers to the creation of a context in which computational resources for meeting the 
challenges will be incorporated into the electronic medical record. The one which he chooses 
is a probabilistic conjoint (Rasch) measurement model (7), which uses scale-free standard 
measures and meets data quality standards. He illustrates this by fitting a set of data 
provided by Bernstein (19)(27 items for the diagnosis of acute myocardial infarction (AMI) 
to a Rasch multiple rating scale model testing the hypothesis that items work together to 
delineate a unidimensional measurement continuum. The results indicated that highly 
improbable observations could be discarded, data volume could be reduced based on its 
internal consistency, and that consistency could be used to increase the ability of the care 
provider to interpret the data. The use of a computer-derived algorithm has been shown to 
aid the physician (8,9). A huge amount of progress has occurred regarding model 
construction and validation in the last 11 years. An ordinal regression (adjacent category 
logit model )(10) used on the AMI problem (11) is superceded by a Latent Class Model of Jay 
Magidson and Jeroen Vermunt (LatentGOLD, Statistical Innovations, Medford, MA)(12). 
The LatentGOLD has LC Cluster models, DFactor models, and LC Regression models and 
has the advantage of allowing performance of LC analyses on data containing more than 
just a few variables. It uses the fundamental methods of model fit (13,14) established as 
Alaike (AIC)(14,15,16) and Bayes (BIC)(14) information criteria. These have not been applied 
to classifying a large and complex medical data set. 
4. Classified data a separate issue from automation 
On the other hand, automation itself may not be as important as the critical value of the 
information provided. The disciplines required in blood banking and in microbiology have 
only been recently automated, but their importance is readily understood with the exception 
of an error in blood sample, or its contamination. To an extent, blood screening has become 
a large scale production to service the user population.  
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The classification of blood types emerged at the turn of the last century firstly as a result of 
the work of Paul Ehrlich (17) establishing a groundwork for immunology, and then later 
Karl Landsteiner’s seminal work in laying the foundation for the blood groups (17). These 
works resulted in a well-defined classification of a set of identified blood group antigens 
and the absence of antibody in the individual’s serum against the blood type, with the 
exception of auto-antibody reactions.  
4.1 Microbiology classification  
Microbiology classification has its origin in the taxonomic principles set down by Bergey’s 
Manual of Determinative Bacteriology, which originated in 1857, and is maintained by 
Bergey’s Trust. It is guided by observable features that are key for separating groups and 
subgroups. The kind of features that we readily identify are gram stain positivity, colonies 
on agar, cocciform or bacillary shape, outer capsule, motility, the clusters formed, the 
metabolic features in growth media, and even the expected antibiotic reactivity. Thus, we 
have an example: in Table 1. 
 
GROUP 4 
Description: Gram Negative, Aerobic/Microaerophilic rods and cocci 
Key differences are: pigments/fluorescent, motility, growth requirements, 
denitrification, 
morphology, and oxidase, read Genera descriptions 
Examples: Acinetobacter, Pseudomonas, Beijerinckia  
GROUP 5 
Description: Facultatively Anaerobic Gram negative rods 
Key differences are: growth factors, morph., gram rxn., oxidase rxn., read Genera 
descriptions  
Examples: Family Enterobacteriaceae and Vibrionaceae 
GROUP 17 
Description: Gram-Positive Cocci 
Key differences are: oxygen requirements, morph., growth requirements (45°C and 
supplements), read Genera descriptions 
Examples: Micrococcus, Staphylococcus, Streptococcus, Enterococcus, Lactococcus 
Table 1. Typical classes of bacteria 
Table 1 does not further divide into subclasses, which requires metabolic differentiation in 
growth media.  
4.2 Feature extraction 
This further breakdown in the modern era is determined by genetically characteristic gene 
sequences that are transcribed into what we measure. Eugene Rypka contributed greatly to 
clarifying the extraction of features in a series of articles, which set the groundwork for the 
methods used today in clinical microbiology (18,19). The method he describes is termed S-
clustering, and will have a significant bearing on how we can view hematology data. He 
describes S-clustering as extracting features from endogenous data that amplify or 
maximize structural information to create distinctive classes. The method classifies by 
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taking the number of features with sufficient variety to map into a theoretic standard. The 
mapping is done by a truth table, and each variable is scaled to assign values for each: 
message choice. The number of messages and the number of choices forms an N-by N table. 
He points out that the message choice in an antibody titer would be converted from 0 + ++ 
+++ to 0 1 2 3. In looking at laboratory values the practitioner separates any test by low 
normal moderately-high high. Even though there may be a large number of measured 
values, the variety is reduced by this compression, even though there is risk of loss of 
information. Yet the real issue is how a combination of variables falls into a table with 
meaningful information. He describes how syndromic classification is uniquely valuable for 
clinical laboratory information by amplifying information in the course of making a pattern-
identifiable syndromic classification. Rudolph, Bernstein and Babb (20) used it for the 
diagnosis of acute myocardial infarction. 
5. Optimal weighting and value assigned to predictor variables 
We are interested in classifying data as essential for determining optimal decision limits for 
tests, and for analyzing variable combinations that are essential and optimal for separating 
the groups that are separated with fewest errors. This is only possible by reducing data 
uncertainty. We are concerned with accurate assignment into uniquely variable groups by 
information in test relationships. One determines the effectiveness of each variable by its 
contribution to information gain in the system. The reference or null set is the class having 
no information. Uncertainty in assigning to a classification is only relieved by providing 
sufficient information. One determines the effectiveness of each variable by its contribution 
to information gain in the system. The possibility for realizing a good model for 
approximating the effects of factors supported by data used for inference owes much to the 
discovery of Kullback-Liebler distance or “information” (21), and Akaike (22) found a 
simple relationship between K-L information and Fisher’s maximized log-likelihood 
function (23). 
5.1 Advances in applied mathematics 
Perhaps the current exponential growth of knowledge since the mapping of the human 
genome a decade ago has been enabled by parallel advances in applied mathematics, which 
has not been a part of the entrance competencies for premedical education, and is now 
taught to some extent in medical and postmedical education for a better understanding of 
modern clinical trials. The knowledge and use of the science of complexity in much of what 
we encounter is brought to account by Ray Kurzweill (24). In a univariate universe, we have 
significant control in visualizing data because we can be confident in separating unlike data 
by methods that rely on distributional assumptions, although errors in assignment can be 
substantial. The median (by rank order assignment is the best method of assignment under 
the circumstances). In reality, there is likely to be a different assignment of predictor values 
given an association with a different disease entity. In order to better define the target 
output another variable is necessary. As we attend to more associated outputs, the number 
of predictors is expanded. Now we begin to have multiple classes delineated by the 
confidence limits of the conjoint predictors. As the number of separate categories increases, 
the size of the database has to increase to limit the error in the so called model 
representation. 
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5.2 Complexity 
As the complexity of models have increased to using several predictors for at least two 
outputs, and the dependencies are not clear, the models used for analysis of the data are 
derived by tables and use of the goodness of fit. The development of the Akaike Information 
Criterion (15,16,21,22,23) brought together two major disciplines that had separate 
developments, information theory and statistics. The powerful tools now available are not 
dependent on distributional assumptions, and allow classification and prediction. In fact 
modeling today has a primary goal of finding an underlying structure in studied data sets. 
A sequence of exploratory programs have been developed by Statistical Innovations, a 
Boston based company founded by Jay Magidson focused on classification problems with 
complex data sets, encompassing a mixture of nominal and continuous predictors, and 
where there is a high complexity with the data sample size may approach the number of 
predictors (CORExpress® , Latent GOLD® 4.5, LG-Syntax Module, Latent GOLD® Choice , 
SI-CHAID® , GOLDMineR). Many articles can be cited concerning these advances (25-32). 
Further, IBM has introduced a software program for Predictive Analytics available in 2011.  
6. Prior experience in similarly developed taxonomies can be applied to 
hematology 
We consider a novel approach to medical inference to have considerable parallel with work 
in bacterial taxonomy, or the rapidly growing work in genomics, proteomics, and 
translational medicine. In the diagnosis of anemia, we divide these into microcytic, 
normocytic and macrocytic. We also consider whether there is proliferation of marrow 
precursors, whether there is domination of a cell line, and whether there is a suppression of 
hematopoiesis. This gives us a two dimensional model. Then we consider another, the 
release into the blood of immature cells, for intermediate to the blast stage. Keep in mind 
that the thalassemias (and hemoglobin H disease) are characterized by moderate to severe 
microcytosis, and there is no anisocytosis (variation in size), and being a genetic disorder in 
production of globin chains, there is a high RBC count, whereas, iron deficiency anemia 
(IDA) differs by lack of iron incorporation into hemoglobin so that there is a low MCV, 
anisocytosis, and a low RBC count so that the ratio (Mentzer’s index) of the MCV/RBC is 
very low with thalassemia, but not in IDA. We shall elaborate more on the creation of an 
evidence-based inference-engine that can substantially interpret the data at hand and 
convert it in real time to a “knowledge-based opinion”, which is improvable from what 
exists today by incorporating clinical features and duration of onset into the model. 
The evaluation of platelet abnormalities is somewhat more limited, but addresses the 
disorders of platelet numbers and of platelet size, and clumping. This does not discern 
abnormalities of platelet function (like von Willebrands, or drug induced). When platelets 
decrease abruptly with disseminated intravascular coagulation (DIC), as in sepsis or with 
massive trauma, the evidence is pretty good.  
6.1 Hematopoiesis 
Figure 1 is a pictorial diagram of hematopoietic cell lineages that are readily found in texts 
and cells are delineated further by identification of cell differentiation (CD) antigens. This 
lineage is expressly important for both the innate response and the humoral response to 
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injury. Our knowledge of the innate response has become more and more intimately 
associated with long term metabolic effects, constitution, and chronic inflammation.  
 
Fig. 1. A common depiction of the evolution of the myeloid and lymphoid cell lines from a 
multipotential hematopoietic stem cell. The platelets, red blood cells, mast cells and myeloid 
series are depicted as derived from a common myeloid progenitor cell. A branching from 
the myeloblast gives the granulocytic cells and the monocyte. Promyelocyte, metamyelocyte 
and myelocyte are intermediates not shown (band neutrophil is viewed as a neutrophil). 
The lymphocyte series is being more defined (as the myelocytic) that the naïve depiction by 
cell differentiation (CD) markers, and interactions are being investigated by cytokine, 
chemokine and cell signaling pathways. 
Figure 1 shows a primary separation into a lymphocytic and a myeloid series. Note that the 
erythrocyte series and platelets are shown to be in lineage from a myeloid progenitor cell. It 
is conceivable that this picture is an oversimplification, but in clinical application, it is 
readily understood. This makes sense with respect to the uncommon evolution of myeloid 
metaplasia into erythroleukemia, but the diagram doesn’t have an obvious connection for 
myelofibrosis, except for in the monocyte-macrophage linkage.  
6.2 Peripheral smear 
The peripheral smear is only viewed on the basis of flagged features seen on the hemogram. 
Blasts, indicative of release of very immature lymphocytes or myeloblasts are flagged and 
have to be reviewed by a pathologist before release, or done by the hematology supervisor 
and retained for pathologist review. In the case of children, there are numerous 
lymphocytes, and there may also be normoblasts and reticulocytes released from an active 
marrow. The presence of small mononuclear cells can be correctly identified by an 
experienced morphologist, but not necessarily by an automated cell counter. Consequently, 
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proportionately more peripheral smears are evaluated for children than for adults. The 
greatest problem in the childhood age group is infection or sepsis. The lymphocyte and 
reticulocyte counts are very high in the infant, and the peak age for acute lymphocytic 
leukemia is at two years old. This makes it far more difficult to identify myelocytes and 
metamyelocytes (not shown in Figure 1), indicators of myeloid proliferation, in children 
than adults (33). The band neutrophil has been used to signify a left shift in myelopoiesis 
associated with sepsis, but it is quite variable and has been largely disregarded. This has 
accounted for the use of an automated cell counter that is also a flow cytometer for 
improved recognition of immature neutrophils below the band count. In the case of the red 
cell series (not shown) we classify first based on the RBC count, and then on the cell size. By 
these measures we have a decrease in mature red cell count based on WHO standards, 
adjusting for menstruation and pregnancy in women. We at the same time consider whether 
the RBC is normocytic, microcytic, or macrocytic and/or megaloblastic. What about 
increased or decreased production? Thalassemia is characterized by small cells that are 
neither hypochromic, or decreased in the peripheral circulation. Platelets may be large, they 
may be excessive in number, or they may be significantly decreased.  
7. Extension of conditions and presentation to the electronic medical record 
(EMR) 
We have published on the application of an automated inference engine (34) to the Systemic 
Inflammatory Response (SIRS), a serious infection, or emerging sepsis. We can report on this 
without going over previous ground. Of considerable interest is the morbidity and mortality of 
sepsis, and the hospital costs from a late diagnosis. If missed early, it could be problematic, 
and it could be seen as a hospital complication when it is not. Improving on previous work, we 
have the opportunity to look at the contribution of a fluorescence labeled flow cytometric 
measurement of the immature granulocytes (IG)(35), which is now widely used, but has not 
been adequatedly evaluated from the perspective of diagnostic usage. We have done 
considerable work on protein-energy malnutrition (PEM)(36-38), to which the automated 
interpretation is currently in review (39). Of course, the cholesterol, lymphocyte count, serum 
albumin provide the weight of evidence with the primary diagnosis (emphysema, chronic 
renal disease, eating disorder), and transthyretin would be low and remain low for a week in 
critical care. This could be a modifier with age in providing discriminating power. 
7.1 Design of EMR 
The current design of the Electronic Medical Record (EMR) is a linear presentation of portions 
of the record by services, by diagnostic method, and by date, to cite examples. This allows 
perusal through a graphical user interface (GUI) that partitions the information or necessary 
reports in a workstation entered by keying to icons. This requires that the medical practitioner 
finds the history, medications, laboratory reports, cardiac imaging and EKGs, and radiology in 
different workspaces. The introduction of a DASHBOARD, a visual panel of essential 
information on the computer screen that is widely used in business organizations, has allowed 
a presentation of drug reactions, allergies, primary and secondary diagnoses, and critical 
information about any patient the care giver needing access to the record. The advantage of 
this innovation is obvious. The startup problem is what information is presented and how it is 
displayed, which is a source of variability and a key to its success. 
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7.2 Dashboard 
We are proposing an innovation that supercedes the main design elements of a 
DASHBOARD and utilizes the conjoined syndromic features of the disparate data elements. 
So the important determinant of the success of this endeavor is that it facilitates both the 
workflow and the decision-making process with a reduction of medical error. This has 
become extremely important and urgent in the 10 years since the publication “To Err is 
Human” (40), and the newly published finding that reduction of error is as elusive as 
reduction in cost. Whether they are counterproductive when approached in the wrong way 
may be subject to debate. 
7.3 Syndromic classification  
In order to clarify the concept of syndromic classification we make a distinction between 
lists of diseases that are assigned to abnormal test results and can be appended to test 
results. The oldest application has been in the identification of bacteria after culture isolation 
using growth in defined media that identify genetically determined metabolic pathways 
characteristic for each organism. A solid foundation in this work was elaborated by Rypka 
(18, 19). This was made less complicated by the genetic complement that defines its function. 
We introduce an AUTOMATED inference engine processing the data and making an 
interpretation available to the ordering physician and can anticipate an enormous impact on 
diagnosis and treatment. It addresses the complexity of inputs and enables rather than 
disables the practitioner. The method identifies outliers and combines data according to 
commonality of features. In some cases there may be conditions that are aggregated by 
similarity and dissimilarity into variants of the same condition with different treatment 
responses. How can we have confidence that we can successfully approach this problem in a 
new way? In the first place we are able to construct an interpretation of the composite data 
that is consistent with how a practitioner views multisystem pathophysiology in service of 
clinical decision-making.  
8. A new inference methodology identifies and classifies anomalies 
The main mathematical breakthroughs are provided by accurate patient profiling and 
inference methodologies in which anomalous subprofiles are extracted and compared to 
potentially relevant cases. Our methodologies organize numerical medical data profiles into 
demographics and characteristics relevant for inference and case tracking. As the model 
grows and its knowledge database is extended, the diagnostic and the prognostic become 
more accurate and precise. 
As an example, inputs from test data such as hematology results are processed for anomaly 
characterization and compared with similar anomalies in a data base of 30,000 patients, 
provide diagnostic statistics, warning flags, and risk assessment. These are based on past 
prior experience, including: diagnostics and treatment outcomes (collective experience). The 
system was trained on this database of patients, built the learning knowledge base and used 
to analysis and diagnosis 5,000 new patients. Our system identified successfully the  
main risks with very high accuracy (more than 96%) and very low false rate (less than 
0.5%)(34). 
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9. Representation and conclusion 
The main benefit is a real time assessment as well as diagnostic options based on 
comparable cases, flags for risk and potential problems as illustrated in Figure 2. Figure 2 
depicts the following case acquired on 04/21/10. The patient was diagnosed by our system 
with severe SIRS. 
 
Fig. 2. The depiction of a patient diagnosed with severe systemic inflammatory response 
syndrome (SIRS), which may evolve into multiple organ failure (MODS), and death by 
circulatory collapse (systemic shock) if not arrested, depending on systemic functional 
reserve and successive stress. The far right is a pie chart of measured effects, and primary 
and secondary diagnoses. The middle lists the diagnoses found above which there is a scale 
with the risk. The left is patient demographics.  
We anticipate that the effect of implementing this diagnostic amplifier would result in 
higher physician productivity at a time of great human resource limitations, safer 
prescribing practices, rapid identification of unusual patients, better assignment of patients 
to observation, inpatient beds, intensive care, or referral to clinic, shortened length of 
patients ICU and bed days. 
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